510(k) Report

510(k) · Cleared

Cleared

Stimpod ST2-3010 Nerve Stimulator

K140853510(k) SpecialCleared Nov 6, 2014217-day reviewClass II21 CFR 868.2775

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Xavant Technology (Pty), Ltd. · BXN Stimulator, Nerve, Battery-Powered

Cleared on Nov 6, 2014 as substantially equivalent to K102084 (Xavant Technology (Pty), Ltd., 2010) after a 217-day review. Its family tree reaches back 5 generations to 1988.

Decided
Nov 6, 2014
Review
217 days
Class
Class II
Product code
BXN
Recalls
None
Predicates
1

Its longest line of descent runs back 5 generations to K882438 (1988). 11 ancestors in all. No later device cites it as a predicate yet.

  1. Root · 5 generations backK882438 Constant Current Peripheral Nerve Stim. #NS252Fisher & Paykel Healthcare, Ltd. · 1988
  2. 4 generations backK023342 Neuro-Trace Iii Kit, Neuro-Trace Iii Regional Block Cable…Hdc Corp. · 2004
  3. 3 generations backK072092 Xpod/Xmap Nerve StimulatorXavant Technology (Pty), Ltd. · 2007
  4. 2 generations backK093591 Stimpod Model NMS-400 Nerve StimulatorXavant Technology (Pty), Ltd. · 2009
  5. 1 generation backK102084 Stimpod NMS450 Nerve StimulatorXavant Technology (Pty), Ltd. · 2010
  6. This deviceK140853 Stimpod ST2-3010 Nerve StimulatorXavant Technology (Pty), Ltd. · 2014
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
−5K882438Constant Current Peripheral Nerve Stim. #NS252Fisher & Paykel Healthcare, Ltd.1988—
−4K023342Neuro-Trace Iii Kit, Neuro-Trace Iii Regional Block Cable, Neuro-Trace Iii…Hdc Corp.2004—
−3K072092Xpod/Xmap Nerve StimulatorXavant Technology (Pty), Ltd.2007—
−2K093591Stimpod Model NMS-400 Nerve StimulatorXavant Technology (Pty), Ltd.2009—
−1K102084Stimpod NMS450 Nerve StimulatorXavant Technology (Pty), Ltd.2010—
0 (this device)K140853Stimpod ST2-3010 Nerve StimulatorXavant Technology (Pty), Ltd.2014—

Other ancestors by year cleared

Year clearedDevicesWith a Class I recall
198810
199620
199910
200110
200510
FIG. 1 — Lineage of K140853, 1988–2014Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in BXN? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Top candidate predicates for a new BXN device

  1. #1 K213049 STIMPOD NMS450 Nerve Stimulatorscore 5.4 · 5 generations · no Class I recall
Get a 510(k) Report

What was it cleared against? (1)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.

TypeNumberDeviceApplicantDecidedRecalls
*K102084Stimpod NMS450 Nerve Stimulator
Summary page 5
…Identification of Predicate Device(s) [21CFR807.92(a)(3)] PREDICATE DEVICES Xavant Technology, STIMPOD NMS450 (K102084) There are no significant differences between the STIMPOD ST2-3010 Nerve Stimulator and the predicate devices which would adver…
Xavant Technology (Pty), Ltd.2010—

Also cleared against K102084: 3 other devices →

What descends from it?

No later submission names this one as a predicate yet.

Has anything in its family been recalled? (0 Class I)

No FDA recall names this device.

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • The line of descent spans 26 years and passes through 3 companies; a new generation was cleared every 3.7 years on median.
  • None of the 11 ancestors has a recall.
  • 3 other devices also cite its predicate K102084.

How does its category compare?

All BXN devices

BXN Stimulator, Nerve, Battery-Powered: FDA decisions, review times, recalls and adverse event reports over 20 years. 2014, this device’s year, is highlighted.

FDA decisions per year · BXN

1in 2022

2007: 32009: 22010: 12011: 22013: 12014: 12015: 12016: 12017: 12022: 1
2007high 3 (2007) · low 0 (2008)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · BXN

108in 2007

2007: 108 days median
2007high 108 (2007)2026

Receipt to decision; years with fewer than 3 clearances left blank.

Recalls per year · BXN

1in 2010

2010: 1
2007high 1 (2010) · low 0 (2007)2026

Class I (0 since 2007) Class II/III not classified

Adverse event reports per year · BXN

4in 2024

2007: 12008: 12009: 12010: 22011: 12012: 52013: 12015: 32017: 12021: 22023: 42024: 4
2007high 5 (2012) · low 0 (2014)2025

MAUDE reports naming product code BXN, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
2007310801
20080—01
20092—01
20101—12
20112—01
20120—05
20131—01
20141—00
20151—03
20161—00
20171—01
20180—00
20190—00
20200—00
20210—02
20221—00
20230—04
20240—04
20250—00
20260—0—

What is it indicated for?

The STIMPOD ST2-3010 is a nerve stimulation device designed to be used for the

purpose of nerve locating using invasive electrodes or needles (not supplied)

Indications for use as stated in the FDA summary.

Cite this page

510(k) Report. “K140853: Stimpod ST2-3010 Nerve Stimulator.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 6, 2026. https://510kreport.com/device/K140853

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026